Durable versus biodegradable polymer drug-eluting stents in all-comers

Durable versus biodegradable polymer drug-eluting stents in all-comers

Background Drug-eluting stents (DESs) have become the gold standard of coronary angioplasty since their inception in 2002. Biodegradable polymer DESs (BP-DESs) have been postulated to be superior to durable polymer DESs (DP-DESs) due to their more biocompatible polymer. To date, no study has shown t...

Full description

Saved in:

Bibliographic Details
Main Authors:	Pascal Meier, Stéphane Cook, MARIO TOGNI, Serban Puricel, Diego Arroyo, Thierry Witzig, Alain Witzig
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2025-03-01
Series:	Open Heart
Online Access:	https://openheart.bmj.com/content/12/1/e003104.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Clinical outcomes of biodegradable polymer biolimus-eluting BioMatrix stents versus durable polymer everolimus-eluting Xience stents.
by: Da Hyon Lee, et al.
Published: (2017-01-01)

Clinical outcomes of ultrathin biodegradable polymer-coated sirolimus-eluting stents in an all-comer population: One-year results from the T-FLEX registry including high-risk subgroups
by: Ramesh Babu Pothineni, et al.
Published: (2021-10-01)

A Randomized Controlled Trial of a Biodegradable Polymer, Microcrystalline Sirolimus-Eluting Stent (MiStent) versus Another Biodegradable Polymer Sirolimus-Eluting Stent (TIVOLI): The DESSOLVE-C Trial
by: Bin Wang, et al.
Published: (2023-03-01)

Thin Strut CoCr Biodegradable Polymer Biolimus A9-Eluting Stents versus Thicker Strut Stainless Steel Biodegradable Polymer Biolimus A9-Eluting Stents: Two-Year Clinical Outcomes
by: Ian B. A. Menown, et al.
Published: (2021-01-01)

Long-term outcomes of biodegradable versus 2nd generation durable polymer drug-eluting stents in PCI: Protocol for a systematic review and meta-analysis.
by: Rosa J Thuemmler, et al.
Published: (2025-01-01)

Sex differences in ST-segment elevation myocardial infarction patients treated by primary percutaneous intervention
by: Pascal Meier, et al.
Published: (2025-01-01)

Comparison of 6-Month and Prolonged Dual Antiplatelet Therapy after Percutaneous Coronary Intervention with Biodegradable Polymer Everolimus-Eluting Stent
by: Yong-Hoon Yoon, et al.
Published: (2022-01-01)

Prospective evaluation of an ultrathin strut biodegradable polymer-coated sirolimus-eluting stent: 12 months’ results from the S-FLEX UK registry
by: Scot Garg, et al.
Published: (2019-10-01)

Polymer-Free Versus Biodegradable Polymer Drug-Eluting Stents in Coronary Artery Disease: Updated Systematic Review and Meta-Analysis of Clinical, Angiographic, and OCT Outcomes
by: Marcello Marchetta, et al.
Published: (2025-06-01)

Favorable Outcomes after Implantation of Biodegradable Polymer Coated Sirolimus-Eluting Stents in Diabetic Population: Results from INDOLIMUS-G Diabetic Registry
by: Anurag Polavarapu, et al.
Published: (2015-01-01)

High HDL-Cholesterol Levels Are Associated With Lower Risk of Acute Coronary Syndromes in Coronary Artery Disease
by: Aurélien Clerc, et al.
Published: (2025-01-01)

Ureteral stent technology: Drug-eluting stents and stent coatings
by: Luo Yang, et al.
Published: (2015-10-01)

One-Year Clinical Outcome of Inspiron Stent in All-Comers Population (Analysis from 790 Consecutive Patients)
by: Felipe Falcão, et al.
Published: (2020-01-01)

Preliminary Evaluation of Clinical and Angiographic Outcomes with Biodegradable Polymer Coated Sirolimus-Eluting Stent in De Novo Coronary Artery Disease: Results of the MANIPAL-FLEX Study
by: Ranjan Shetty, et al.
Published: (2016-01-01)

Drug-eluting versus bare-metal stent for treatment of saphenous vein grafts: a meta-analysis.
by: Pascal Meier, et al.
Published: (2010-06-01)

Paclitaxel eluting stents versus bare metal stents restenosis
by: Ronald Aroche Aportela, et al.
Published: (2021-12-01)

Impact of Arterial Stiffness on In-Stent Restenosis in the Era of Drug-Eluting Stents
by: Yiquan Huang, et al.
Published: (2025-06-01)

Clinical Outcomes of Drug-Eluting versus Bare-Metal In-Stent Restenosis after the Treatment of Drug-Eluting Stent or Drug-Eluting Balloon: A Systematic Review and Meta-Analysis
by: Yi-Xing Yang, et al.
Published: (2020-01-01)

Comparison of the Efficacy of Everolimus-Eluting Stents and Paclitaxel-Eluting Balloon Angioplasty for Coronary In-Stent Restenosis: A Systematic Review and Meta-Analysis
by: Zhili Wei, et al.
Published: (2025-06-01)

Synthesis and Appraisal of Natural Drug-Polymer-Based Matrices Relevant to the Application of Drug-Eluting Coronary Stent Coatings
by: Bakhtawar Ghafoor, et al.
Published: (2020-01-01)

Drug Release Analysis and Optimization for Drug-Eluting Stents
by: Hongxia Li, et al.
Published: (2013-01-01)

Risk assessment score for drug eluting stent restenosis
by: Z. A. Gabbasov, et al.
Published: (2018-09-01)

Late Thrombosis of Sirolimus-Eluting Stent: A Multifactorial Problem
by: Igor Kranjec, et al.
Published: (2009-01-01)

MODERN COATING TECHNOLOGIES FOR DRUG ELUTING CORONARY STENTS (REVIEW)
by: E. Y. Zagorulko, et al.
Published: (2019-01-01)

A Strategy for the In-Silico Assessment of Drug Eluting Stents: A Comparative Study for the Evaluation of Retinoic Acid as a Novel Drug Candidate for Drug Eluting Stents
by: Dimitrios S. Pleouras, et al.
Published: (2025-01-01)

Drug-Eluting Balloons versus Second-Generation Drug-Eluting Stents for Treating In-Stent Restenosis in Coronary Heart Disease after PCI: A Meta-Analysis
by: Wen-Juan Xiu, et al.
Published: (2018-01-01)

Epilepsia ao comer
by: Monica S. Haddad, et al.
Published: (1991-09-01)

Saphenous Vein Graft Aneurysm after Drug-Eluting Stent Implantation: Treatment by Covered Stent
by: Kyriacos Papadopoulos, et al.
Published: (2021-01-01)

Subacute Drug-Eluting Stent Thrombosis Caused by Stent Underexpansion: Evaluation by Optical Coherence Tomography
by: Roberto Martín-Reyes, et al.
Published: (2011-01-01)

Stents biodegradables en cardiología
by: Geovedy Martínez García, et al.

Medication eluting devices for the field of OBGYN (MEDOBGYN): 3D printed biodegradable hormone eluting constructs, a proof of concept study.
by: Karthik Tappa, et al.
Published: (2017-01-01)

Utopías y sueños: El deseo de comer mucho y comer bien
by: María Ángeles Pérez Samper
Published: (2015-05-01)

Endovascular Treatment with Limus Eluting Stents in Patients with Acute Coronary Syndrome
by: M. V. Chernyayev, et al.
Published: (2019-04-01)

How real is a threat of late thrombosis for drug-eluting stents? Stent comparison and focus on everolimus
by: V. P. Lupanov, et al.
Published: (2009-10-01)

Safety and Efficacy of Cobalt Chromium Everolimus‐Eluting Stents for Treatment of In‐Stent Restenosis: An ILUMIEN IV Substudy
by: Ziad A. Ali, et al.
Published: (2025-06-01)

Study on the potential clinical significance of subclinical stent edge effects after drug-eluting stent implantation
by: Yi Xu, et al.
Published: (2025-03-01)

Risk Factors and Incidence for In-Stent Restenosis with Drug-Eluting Stent: A Systematic Review and Meta-Analysis
by: Birong Liu, et al.
Published: (2024-12-01)

Risk Factors of Coronary In–Stent Restenosis in Drug-Eluting Stent: A Systematic Review and Meta-Analysis
by: Hotmauli Siahaan, et al.
Published: (2025-07-01)

The Predictors of Target Lesion Revascularization and Rate of In-Stent Restenosis in the Second-Generation Drug-Eluting Stent Era
by: Chengbin Zheng, et al.
Published: (2019-01-01)

In-stent restenosis of drug-eluting stents in patients with diabetes mellitus: Clinical presentation, angiographic features, and outcomes
by: Ganesh Paramasivam, et al.
Published: (2019-12-01)